Hockman A, Anuskiewicz S, Brennan E, et al. Efficacy of eculizumab discontinuation in atypical hemolytic uremic syndrome: a systematic review and meta-analysis. Blood Adv. 2025;9(23):6096-6107. [PDF]
europepmc +1 more source
Multidisciplinary management of concurrent postpartum eclampsia, HELLP syndrome, ruptured hepatic subcapsular hematoma, and atypical hemolytic uremic syndrome: a case report. [PDF]
Liang Y +6 more
europepmc +1 more source
C3 p.Asp1115Asn Variant-associated Atypical Hemolytic Uremic Syndrome with Spontaneous Remission Triggered by Influenza and COVID-19. [PDF]
Fujino Y +12 more
europepmc +1 more source
Atypical Hemolytic Uremic Syndrome Triggered by COVID-19 Infection in a Pediatric Patient With CD46 Mutation. [PDF]
Lorestani P, Maleki Dana P, Tohidi MR.
europepmc +1 more source
Atypical hemolytic uremic syndrome treated with anti-C5 antibody agent eculizumab, without genetic complement abnormalities. [PDF]
Sato Y +10 more
europepmc +1 more source
Atypical hemolytic uremic syndrome: a rare complication of postendoscopic retrograde cholangiopancreatography pancreatitis. [PDF]
Nanagiri A +4 more
europepmc +1 more source
Real-World effectiveness of eculizumab in atypical hemolytic uremic syndrome: a retrospective study from Western China. [PDF]
Hu Y, Zhang Y, Wang W, Li G, Chen S.
europepmc +1 more source
Ocular Manifestations in Atypical Hemolytic Uremic Syndrome Treated With Ravulizumab: A Case Report and Review of the Literature. [PDF]
Flindris K +6 more
europepmc +1 more source
Atypical hemolytic uremic syndrome: diagnosis, management, and discontinuation of therapy. [PDF]
Java A.
europepmc +1 more source
Hypertensive Emergency and Atypical Hemolytic Uremic Syndrome Associated with Cocaine Use: A Diagnostic and Therapeutic Challenge. [PDF]
Jiménez Mayor E +7 more
europepmc +1 more source

